EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methionine restriction inhibits the TGF-β1/CCN2/NF-κB pathway to attenuate astrocyte inflammation and cognitive impairment in the APP/PS1 mice

Huan Liu, Ni Zheng, Zhi Zhang, Shuang Wu, Shuyi Yu, Yunshan Wang, Zhenfang Dong, Shuai Zong, Xueying Wang, Zhiming Lu

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Huan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China. Hauptthemen laut MEDLINE: Methionine, Astrocytes, Cognitive Dysfunction, Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a neurodegenerative condition characterized by cognitive impairment. Astrocytes are involved in AD by clearing amyloid-beta peptide (Aβ) and regulating neuroinflammation. In recent years, methionine restriction (MR) has attracted increasing attention for its benefits in extending lifespan and inhibiting tumor growth. However, the molecular mechanisms underlying the alleviation of astrocyte-mediated neuroinflammation by MR to delay the progression of AD are not well understood. This study determined the existence of the methionine cycle in astrocytes, which was disorganized in AD models. After 4 months of MR dietary intervention, APP/PS1 mice showed improved cognitive function, reduced neuronal loss, decreased Aβ plaque burden, increased dendritic spine density, and lower astrocyte abnormal activation. RNA sequencing of APP/PS1 mouse hippocampal tissue revealed that MR reduced neuroinflammation by downregulating the TGF-β1/CCN2 signaling pathway. Both in vitro and in vivo experiments demonstrated that MR down-regulated CCN2 expression, which in turn reduced the level of neuroinflammation. Moreover, CCN2 downregulation was accompanied by suppression of the NF-κB signaling pathway. This study showed that MR reduced the inflammation mediated by astrocytes and cognitive decline in AD by blocking the TGF-β1/CCN2/NF-κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethionineAstrocytesCognitive DysfunctionAlzheimer DiseaseSignal TransductionAnimalsMiceDisease Models, AnimalNF-kappa BTransforming Growth Factor beta1Neuroinflammatory DiseasesDown-RegulationRNA-SeqMice, Inbred C57BLMice, TransgenicDietCalponinsCalmodulin-Binding ProteinsMicrofilament Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseAstrocytesCCN2Methionine restrictionNeuroinflammation

Substanzen

MethionineCnn2 protein, mouseTgfb1 protein, mouseNF-kappa BTransforming Growth Factor beta1CalponinsCalmodulin-Binding ProteinsMicrofilament Proteins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China.
  • Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.
  • Department of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China; Department of Clinical Laboratory, Shandong Provincial Hospital Affiliate…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, H., Zheng, N., Zhang, Z., Wu, S., Yu, S., Wang, Y., Dong, Z., Zong, S., Wang, X., & Lu, Z. (2025). Methionine restriction inhibits the TGF-β1/CCN2/NF-κB pathway to attenuate astrocyte inflammation and cognitive impairment in the APP/PS1 mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115498

Vancouver

Liu H, Zheng N, Zhang Z, Wu S, Yu S, Wang Y, et al. Methionine restriction inhibits the TGF-β1/CCN2/NF-κB pathway to attenuate astrocyte inflammation and cognitive impairment in the APP/PS1 mice. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115498

BibTeX
@article{Liu2025,
  author = {Liu, Huan and Zheng, Ni and Zhang, Zhi and Wu, Shuang and Yu, Shuyi and Wang, Yunshan and Dong, Zhenfang and Zong, Shuai and Wang, Xueying and Lu, Zhiming},
  title = {Methionine restriction inhibits the TGF-β1/CCN2/NF-κB pathway to attenuate astrocyte inflammation and cognitive impairment in the APP/PS1 mice},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115498}
}
Kostenlos starten →